Commerzbank (ETR:CBK)‘s stock had its “sell” rating reissued by investment analysts at DZ Bank in a research note issued to investors on Friday.

A number of other equities analysts have also weighed in on CBK. Royal Bank of Canada set a €9.00 ($10.71) price objective on Commerzbank and gave the company a “neutral” rating in a research note on Friday, December 8th. Morgan Stanley set a €11.10 ($13.21) price objective on Commerzbank and gave the company a “neutral” rating in a research note on Wednesday. UBS reiterated a “neutral” rating on shares of Commerzbank in a research note on Monday. Goldman Sachs Group set a €10.50 ($12.50) price objective on Commerzbank and gave the company a “neutral” rating in a research note on Wednesday, December 6th. Finally, Deutsche Bank set a €9.00 ($10.71) price objective on Commerzbank and gave the company a “neutral” rating in a research note on Tuesday, September 26th. Five investment analysts have rated the stock with a sell rating, twelve have given a hold rating and one has given a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of €10.22 ($12.17).

Commerzbank (ETR CBK) opened at €12.53 ($14.91) on Friday. Commerzbank has a 52 week low of €6.97 ($8.30) and a 52 week high of €12.83 ($15.27).

TRADEMARK VIOLATION WARNING: “DZ Bank Reiterates “Sell” Rating for Commerzbank (CBK)” was originally published by American Banking News and is owned by of American Banking News. If you are accessing this article on another domain, it was stolen and republished in violation of US & international copyright law. The correct version of this article can be viewed at https://www.americanbankingnews.com/2017/12/15/dz-bank-reiterates-sell-rating-for-commerzbank-cbk.html.

Commerzbank Company Profile

Analyst Recommendations for Commerzbank (ETR:CBK)

Receive News & Ratings for Commerzbank Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Commerzbank and related companies with MarketBeat.com's FREE daily email newsletter.